Literature DB >> 25087507

Antibacterial efficacy of acridine derivatives conjugated with gold nanoparticles.

Piyali Mitra1, Prabal Kumar Chakraborty2, Partha Saha2, Pulak Ray3, Samita Basu4.   

Abstract

Adsorption of acridine derivatives viz. 9-aminoacridine hydrochloride hydrate (9AA-HCl), acridine yellow (AY), acridine orange (AO), and proflavine (Pro) on citrate stabilized gold nanoparticle surface were studied using different analytical techniques like UV-vis absorption spectroscopy, Fourier transform infrared spectroscopy (FT-IR), and transmission electron microscopy (TEM). The amine moiety of acridine derivative binds strongly to the gold nanoparticles as confirmed by spectroscopic studies. The plasmon band observed for the wine red colloidal gold at 525 nm in the UV-vis spectrum is characteristic of gold nanoparticles. However, with the addition of acridine derivatives the intensity of the absorption band at 525 nm decreases and a new peak emerges at red-end region - a signature of formation of gold-drug complex. The TEM images show the average size of citrate stabilized gold nanoparticles as 15-20 nm, which becomes larger in the presence of various drugs due to aggregation. From the thermogravimetric analyses (TGA) we have measured the number of drug molecules attached per gold nanoparticle (AuNP). These gold nanoparticles are very important as drug delivery vehicles and for clinical applications it is necessary to understand their activity in vivo. The antibacterial efficacy of drugs coated gold nanoparticles were studied against various strains of Gram positive and Gram negative bacteria. Among the four drugs, 9AA-HCl and AO showed antibacterial activity and for both of them the AuNP conjugated drug showed better antibacterial efficacy than the bare drug. Because of the high penetrating power and large surface area of Au(0), a single gold nanoparticle can adsorb multiple drug molecules, hence this total entity acts as a single group against the bacteria.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial efficacy; Covalently modified; Nanoparticles; Transmission electron microscope

Mesh:

Substances:

Year:  2014        PMID: 25087507     DOI: 10.1016/j.ijpharm.2014.07.051

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  7 in total

Review 1.  Synthesis of gold nanomaterials and their cancer-related biomedical applications: an update.

Authors:  Saravanan Govindaraju; Kyusik Yun
Journal:  3 Biotech       Date:  2018-02-05       Impact factor: 2.406

Review 2.  Topographical nanostructures for physical sterilization.

Authors:  Yujie Cai; Wei Bing; Xiao Xu; Yuqi Zhang; Zhaowei Chen; Zhen Gu
Journal:  Drug Deliv Transl Res       Date:  2021-02-04       Impact factor: 4.617

3.  Gold Nanoparticle-Mediated Targeted Delivery of Recombinant Human Endostatin Normalizes Tumour Vasculature and Improves Cancer Therapy.

Authors:  Wei Li; Xiaoxu Zhao; Bin Du; Xin Li; Shuhao Liu; Xiao-Yan Yang; Hui Ding; Wende Yang; Fan Pan; Xiaobo Wu; Li Qin; Yunlong Pan
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

4.  Bromelain capped gold nanoparticles as the novel drug delivery carriers to aggrandize effect of the antibiotic levofloxacin.

Authors:  Paramdeep Bagga; Tarique Mahmood Ansari; Hefazat Hussain Siddiqui; Asad Syed; Ali H Bahkali; Md Azizur Rahman; Mohd Sajid Khan
Journal:  EXCLI J       Date:  2016-12-06       Impact factor: 4.068

5.  Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels.

Authors:  Xiaoxu Zhao; Jinghua Pan; Wei Li; Wende Yang; Li Qin; Yunlong Pan
Journal:  Int J Nanomedicine       Date:  2018-10-09

6.  Antibacterial and Photocatalytic Properties of ZnO-9-Aminoacridine Hydrochloride Hydrate Drug Nanoconjugates.

Authors:  Piyali Mitra; Debanjan Dutta; Somnath Das; Tarakdas Basu; Amitava Pramanik; Amitava Patra
Journal:  ACS Omega       Date:  2018-07-17

7.  Porphyrin-Gold Nanomaterial for Efficient Drug Delivery to Cancerous Cells.

Authors:  Kaushik Bera; Samarpan Maiti; Mritunjoy Maity; Chitra Mandal; Nakul C Maiti
Journal:  ACS Omega       Date:  2018-04-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.